"These are ideal things that outperform humans to come out with real answers" – Professor Ronjon Nag on AI and Biotech

Artificial intelligence and biotechnology are converging to create ground-breaking opportunities for investors and innovators alike. Speaking at SuperVenture North America, Ronjon Nag, Founder of R42 Group Family Office and Adjunct Professor, shared his expert insights into the rapidly evolving AI and biotech landscape. From identifying the most exciting emerging industries to separating market hype from meaningful innovation, Ronjon provided a roadmap for investors navigating these dynamic sectors. His work on an anti-aging vaccine adds a fascinating perspective on the potential of biotech to transform the future.

How can investors make the most of the AI and biotech revolution? Explore the emerging industries driving innovation, tips for investing in AI and biotech, and how to distinguish real opportunities from hype. Plus, learn about Ronjon’s groundbreaking work on an anti-aging vaccine.